Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does

Sandrine Lecour1

  • 1Cardioprotection Group, Hatter Cardiovascular Research Institute, Department of Medicine, Chris Barnard Building, Faculty of Health Sciences, University of Cape Town, 7925 Observatory, South Africa.

Insights

Tumor necrosis factor alpha (TNFα) paradoxically activates a novel cardiac protective pathway, the Survivor Activating Factor Enhancement (SAFE) pathway, reducing lethal reperfusion injury. This SAFE pathway, involving STAT-3, offers a new therapeutic target for acute myocardial infarction.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Lethal reperfusion injury is a significant complication of acute myocardial infarction treatment.
  • The heart possesses intrinsic mechanisms to protect against reperfusion-induced cell death.
  • Tumor necrosis factor alpha (TNFα) is typically associated with myocardial dysfunction.

Purpose of the Study:

  • To review evidence for a novel protective pathway initiated by TNFα against reperfusion injury.
  • To introduce the Survivor Activating Factor Enhancement (SAFE) pathway.
  • To explore the SAFE pathway's interaction with the Reperfusion Injury Salvage Kinase (RISK) pathway and its therapeutic potential.

Main Methods:

  • Review of existing scientific literature on TNFα, reperfusion injury, and cardiac signaling pathways.
  • Analysis of evidence supporting the role of signal transducer and activator of transcription 3 (STAT-3) in cardioprotection.
  • Comparison of the SAFE pathway with the established RISK pathway (involving Akt and Erk 1/2).

Main Results:

  • TNFα can paradoxically activate a protective signaling cascade, the SAFE pathway.
  • The SAFE pathway requires STAT-3 activation and limits cardiomyocyte death during reperfusion.
  • The SAFE pathway operates independently of the RISK pathway.

Conclusions:

  • The SAFE pathway represents a novel intrinsic cardiac protection mechanism against lethal reperfusion injury.
  • Understanding the SAFE pathway's interplay with the RISK pathway is crucial for therapeutic development.
  • Targeting the SAFE pathway holds potential for protecting hearts from reperfusion damage in clinical settings.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...